The English summary for this medicine is temporarily unavailable while its source data is reviewed.
Sodium hyaluronate 0.7% ocular viscoelastic agent 1% “Alcon”
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).